Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Opens Door For J&J's Spravato To Another MDD Population
Aug 03 2020
•
By
Jessica Merrill
J&J's Spravato is approved for a new depression indication • Source: Shutterstock
More from Neurological
More from Therapeutic Category